论文部分内容阅读
目的分析阿仑膦酸钠及维生素D_3治疗老年女性骨质疏松症的临床效果。方法从我院2014年4月—2016年4月收治的老年骨质疏松症女性患者中选取80例,并依据患者入院的时间顺序将其进行编号,随机分为对照组及观察组,每组40例。对照组患者口服阿仑膦酸钠,观察组患者在此基础上加用维生素D_3,治疗3个月。结果观察组患者治疗总有效率为85.0%,明显高于对照组的55.0%(P<0.05)。结论阿仑膦酸钠与维生素D_3在安全性、耐受性方面有着不可比拟的优势,可有效提高老年女性骨质疏松患者骨密度,值得临床推广应用。
Objective To analyze the clinical efficacy of alendronate and vitamin D_3 in the treatment of elderly women with osteoporosis. Methods Eighty female patients with senile osteoporosis who were admitted to our hospital from April 2014 to April 2016 were selected according to their time of admission and were randomly divided into control group and observation group. 40 cases. The patients in the control group were given oral alendronate. The patients in the observation group were given vitamin D_3 on this basis for 3 months. Results The total effective rate of observation group was 85.0%, significantly higher than that of the control group (55.0%, P <0.05). Conclusion Alendronate and vitamin D_3 have unparalleled advantages in safety and tolerability, which can effectively improve the bone mineral density in elderly women with osteoporosis, which is worthy of clinical application.